Fujitsu launches new cloud-based platform for healthcare sector in Japan, promoting personalized healthcare and drug development
Retrieved on:
Tuesday, March 28, 2023
Insurance, Allergy, Ministry of Internal Affairs and Communications, Drug development, Information system, Process safety management, MHLW, Health informatics, Internet of things, Health Level Seven International, Communication, Internal affairs, Microsoft, FHIR, Research, Doctor of Philosophy, Problem-Oriented Medical Information System, Behavior, Sapporo Medical University, Development, Healthy Living, Data analysis, MD, Patient, Collection, Health Level 7, Diagnosis, Azure, HL7, AI, Perelman Center for Advanced Medicine, Security Technical Implementation Guide, Education, Health information exchange, Disease, Pharmaceutical industry, Medical device, Medical imaging, Nursing, Health care, Life, Health, Fujitsu
Fujitsu will offer the new platform to medical institutions and pharmaceutical companies in Japan starting March 28, 2023.
Key Points:
- Fujitsu will offer the new platform to medical institutions and pharmaceutical companies in Japan starting March 28, 2023.
- "Microsoft is utilizing cloud services and AI technologies in the healthcare field and promoting the next generation standards framework HL7 FHIR.
- Health Level Seven, Inc. is an organization dedicated to developing and promoting standards for healthcare information.
- Health Level Seven, Inc. is an organization dedicated to developing and promoting standards for healthcare information.